Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1980-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.17.6.912PMID 6931548PMCID PMC283902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thienamycin: New Beta-Lactam Antibiotic with Potent Broad-Spectrum Activity

  1979cited by this paper
• In Vitro Activity of Thienamycin

  1978cited by this paper
• Structure and absolute configuration of thienamycin

  1978cited by this paper
• Binding of Thienamycin and Clavulanic Acid to the Penicillin-Binding Proteins of Escherichia coli K-12

  1977cited by this paper

• Cheminformatics Study on Structural and Bactericidal Activity of Latest Generation β-Lactams on Widespread Pathogens

  2022cites this paper
• Correlation study of antibacterial activity and spectrum of Penicillins through a structure-activity relationship analysis

  2019cites this paper
• Etymologia: Carbapenem

  2019cites this paper
• SYNERGISTIC ACTIONS OF RUBIA CORDIFOLIA STEM EXTRACT WITH MEROPENEM AND POLYMYXIN B AGAINST DIFFERENT BACTERIA

  2019cites this paper
• Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA

  2019cites this paper
• A review on anti‐tuberculosis peptides: Impact of peptide structure on anti‐tuberculosis activity

  2019cites this paper
• Ideal Growth Conditions for Elizabethkingia meningoseptica

  2016cites this paper
• Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages.

  2015cites this paper
• Development of Antituber- cular Agents: Potential for β-lactum Based

  2015cites this paper
• Applications of Natural Products from Soil Microbes

  2015cites this paper
• Methods to measure target site penetration of antibiotics in critically ill patients.

  2013cites this paper
• Automatic phylogenetic Classification of bacterial beta-Lactamase Sequences including Structural and Antibiotic substrate Preference Information

  2013cites this paper
• Structural and biochemical investigation of Metallo-β-lactamases : insights into antibiotic binding sites

  2012cites this paper
• THE ORIGIN OF PHARMACEUTICALS

  2012cites this paper
• β‐Lactam Antibiotics

  2012cites this paper
• Importance of Position 170 in the Inhibition of GES-Type β-Lactamases by Clavulanic Acid

  2011cites this paper
• Purification and characterization of a salt tolerant metallo-beta-lactamase from Aliivibrio salmonicida

  2011cites this paper
• Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages.

  2009cites this paper
• Class A carbapenemases.

  2007cites this paper
• Imipenem/Cilastatin

  2005cites this paper
• Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin and gentamicin

  2005cites this paper
• In Vitro Activity of Tebipenem, a New Oral Carbapenem Antibiotic, against Penicillin-Nonsusceptible Streptococcus pneumoniae

  2005cites this paper
• Quantification of Imipenem’s Primary Metabolite in Plasma by Postcolumn Chemical Rearrangement and UV Detection

  2004cites this paper
• Microwave In Organic Synthesis: Myth Or Reality?

  2004cites this paper
• Novel C-2 substituted carbapenem derivatives. Part III. Synthesis and biological activity of 2-(functionalised ethenyl, oxyiminomethyl and alpha-[hydroxy]benzyl)-carbapenems.

  1997cites this paper
• Treatment of septicemia with imipenem/cilastatin sodium in very-low birth weight infants

  1996cites this paper
• Imipenem and immune response: in vitro and in vivo studies.

  1995cites this paper
• In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity

  1993cites this paper
• Human plasma and aqueous humor determination of imipenem by liquid chromatography with ultraviolet detection

  1993cites this paper
• Imipenem Reaches Therapeutic Concentrations in Aqueous Humor, as Determined by Hplc

  1993cites this paper
• Principles of Antimicrobial Therapy

  1992cites this paper
• Mechanisms of bacterial resistance to antibiotics.

  1991cites this paper
• Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a klebsiella pneumoniae producing an extended-spectrum β-lactamase

  1991cites this paper
• Coagulase-Negative Staphylococci: Incidence, Pathogenicity, and Treatment in the 1990S

  1990cites this paper
• In vitro activity of 9 antimicrobial agents against 177 strains of Haemophilus influenzae isolated from hospitalized patients

  1990cites this paper
• Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography.

  1990cites this paper
• In vitro and in vivo effects of Imipenem on phagocytic activity of murine peritoneal macrophages

  1989cites this paper
• [In vitro susceptibility to a new antimicrobial agent (imipenem) of pathogens isolated from inpatients at various centers].

  1989cites this paper
• Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States.

  1989cites this paper
• Estudo da suscetibilidade "in vitro" a um novo antimicrobiano (IMIPENEM) de patógenos isolados de pacientes hospitalares em vários centros

  1989cites this paper
• [Sensitivity of Campylobacter to 2 new groups of beta-lactams].

  1988cites this paper
• Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem

  1988cites this paper
• Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections

  1987cites this paper
• Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats

  1987cites this paper
• Penetration of imipenem and other antibiotics into inflammatory exudate and their efficacy in pseudomonas infection in the rat granuloma pouch model.

  1987cites this paper
• Determination of N-formimidoylthienamycin concentration in sera from pediatric patients by high-performance liquid chromatography.

  1986cites this paper
• [Fundamental and clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].

  1986cites this paper
• Imipenem-cilastatin: the first thienamycin antibiotic.

  1986cites this paper
• Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.

  1986cites this paper
• Effect of imipenem-cilastatin therapy on fecal flora

  1986cites this paper
• Imipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections

  1986cites this paper
• Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins.

  1986cites this paper
• Biotyping and phage typing of coagulase-negative staphylococci from blood cultures of neonates.

  1986cites this paper
• Wirkung und Verträglichkeit von täglich 2×1 g Imipenem/Cilastatin in der Allgemeinchirurgie

  1986cites this paper
• Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.

  1986cites this paper
• [Effect and tolerance of daily 2 X 1 g imipenem/cilastatin in general surgery].

  1986cites this paper
• 産婦人科領域におけるImipenem/Cilastatin sodiumの臨床的検討

  1986cites this paper
• 小児科領域におけるImipenem/Cilastatin sodiumの臨床的検討

  1986cites this paper
• Pharmacokinetics of imipenem-cilastatin in neonates

  1985cites this paper
• Imipenem (MK-0787), Cilastatin sodium (MK-0791), MK-0787/MK-0791臨床第一相試験

  1985cites this paper
• 外科領域におけるImipenem/Cilastatin sodium (MK-0787/MK-0791) の臨床的検討

  1985cites this paper
• In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.

  1985cites this paper
• Efficacy of imipenem/cilastatin in endocarditis.

  1985cites this paper
• Pathogenesis and treatment of endocarditis.

  1985cites this paper
• Endemic nosocomial Acinetobacter calcoaceticus bacteremia. Clinical significance, treatment, and prognosis.

  1985cites this paper
• Imipenem: first of a new class of beta-lactam antibiotics.

  1985cites this paper
• Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.

  1985cites this paper
• In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents

  1985cites this paper
• Comparative in-vitro activity of Sch 34343, a new penem antibiotic.

  1985cites this paper
• Empirical use of imipenem as the sole antibiotic in the treatment of serious infections.

  1985cites this paper
• In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria

  1985cites this paper
• Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis.

  1985cites this paper
• Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.

  1985cites this paper
• Imipenem/cilastatin for the treatment of infections in hospitalized children.

  1985cites this paper
• Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis

  1985cites this paper
• Antibacterial activity of imipenem: the first thienamycin antibiotic.

  1985cites this paper
• Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.

  1985cites this paper
• Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C

  1985cites this paper
• In vitro activity of imipenem against anaerobic bacteria.

  1985cites this paper
• Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stability.

  1984cites this paper
• In vitro activity of imipenem — A review

  1984cites this paper
• Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections

  1984cites this paper
• Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.

  1984cites this paper
• Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography

  1984cites this paper
• Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus

  1984cites this paper
• Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli.

  1984cites this paper
• [Beta-lactamase inhibitors and their possible therapeutic significance].

  1984cites this paper
• Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis

  1984cites this paper
• Susceptibility ofLegionella spp. to imipenem and 27 other beta-lactam antibiotics

  1984cites this paper
• The affinity of imipenem (N-formimidoylthienamycin) for the penicillin-binding proteins of Staphylococcus aureus--binding and release.

  1984cites this paper
• Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.

  1984cites this paper
• Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873

  1984cites this paper
• Pharmacokinetics of N-formimidoyl thienamycin and influence of a renal dipeptidase inhibitor in experimental meningitis.

  1983cites this paper
• Comparative study of imipenem in severe infections.

  1983cites this paper
• An evaluation of recently developed antibiotics.

  1983cites this paper
• A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin.

  1983cites this paper
• Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.

  1983cites this paper
• Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci

  1983cites this paper
• Thienamycin: development of imipenen-cilastatin.

  1983cites this paper
• Synergistic Effect of N-Formimidoyl Thienamycin with Gentamicin and Amikacin Against Streptococcus faecalis

  1983cites this paper